Brexucabtagene autoleucel shows promising efficacy and safety in treating relapsed B-cell acute lymphoblastic leukemia, including patients with CNS involvement.
Tony Berberabe, MPH
Advertisement
Articles by Tony Berberabe, MPH
Encouraging trends were seen with osimertinib and platinum-pemetrexed chemotherapy in patients with EGFR-mutated advanced non–small cell lung cancer (NSCLC) in the phase 3 FLAURA2 study.
Advertisement
Latest Updated Articles
Regardless of CNS Involvement, Patients With B-ALL Benefit From Brexu-CelPublished: August 23rd 2025 | Updated:
- Fine Print of Budget Deal Doesn't Bode Well for SGR Overhaul
Published: February 12th 2014 | Updated:
- Physician Practices, Healthcare Organizations See Own Staff as Source of Security Breaches
Published: March 20th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Withdrawal of Aid Could Cause Millions of Lives Lost to HIV
2
EASO Recommends Semaglutide, Tirzepatide for First-Line Obesity Therapy
3
Recent FDA Approvals Expand Dermatology Options for Patients With Skin of Color
4
Opportunities and Obstacles Associated With the Medicare Diabetes Prevention Program
5
